Neuroblastoma surgery: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neuroblastoma}} | {{Neuroblastoma}} | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}}{{ZAS}}{{HL}} | ||
==Overview== | ==Overview== | ||
==Surgery== | ==Surgery== | ||
Revision as of 14:33, 28 February 2019
|
Neuroblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neuroblastoma surgery On the Web |
|
American Roentgen Ray Society Images of Neuroblastoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]Haytham Allaham, M.D. [3]
Overview
Surgery
- Surgical intervention alone may be curative as a single therapeutic modality for the management of low risk neuroblastoma patients.
- Surgical intervention must be followed by chemotherapy for the management of intermediate risk neuroblastoma patients.
- The potential benefit of aggressive surgical approaches to achieve complete tumor resection in high-risk patients with metastatic disease has not been clearly demonstrated.[1]
- Surgical complications following neuroblastoma resection may include:[2]
- Intussusception
- Internal haemorrhage due to vessel injuries
- Nerve injuries
References
- ↑ Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015
- ↑ Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015